<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140018" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pyocystis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brownlee</surname>
            <given-names>Holly C.</given-names>
          </name>
          <aff>Musgrove Park Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Richards</surname>
            <given-names>James</given-names>
          </name>
          <aff>Musgrove Park Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Trent</surname>
            <given-names>Neil D.</given-names>
          </name>
          <aff>Musgrove Park Hopital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Holly Brownlee declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>James Richards declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Neil Trent declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140018.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pyocystis is a severe form of lower urinary tract infection that results from the collection of purulent debris within the bladder. Pyocystis is sometimes referred to in the literature as &#x02018;empyema cystis&#x02019; and &#x02018;vesical empyema.&#x02019; Pyocystis is an uncommon condition that occurs exclusively in the defunctionalized bladder. It can cause a severe systemic infection and result in prolonged hospital stays, surgery, and death. To optimize outcomes and reduce morbidity, early identification and treatment must occur. This activity reviews the evaluation and treatment of patients with pyocystis and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the pathophysiology of pyocystis.</p></list-item><list-item><p>Identify the risk factors that make a patient susceptible to developing pyocystis.</p></list-item><list-item><p>Summarize the treatment options for patients with pyocystis.</p></list-item><list-item><p>Describe the Spence-Allen procedure and its role in the management of pyocystis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140018&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140018">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140018.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pyocystis is a rare but severe lower urinary tract infection resulting in a collection of infected debris accumulating within the bladder.<xref ref-type="bibr" rid="article-140018.r1">[1]</xref>&#x000a0;Other terms used for this condition are&#x000a0;&#x02018;vesical empyema&#x02019; and &#x02018;empyema cystis.&#x02019;<xref ref-type="bibr" rid="article-140018.r2">[2]</xref><xref ref-type="bibr" rid="article-140018.r3">[3]</xref>&#x000a0;Most frequently, this condition occurs in the defunctionalized bladder&#x000a0;of patients who have undergone a pre-vesicular urinary diversion procedure without a subsequent cystectomy.<xref ref-type="bibr" rid="article-140018.r1">[1]</xref>&#x000a0;These patients may have either a continent, categorizable diversion, or a urostomy (usually ileal conduit).<xref ref-type="bibr" rid="article-140018.r4">[4]</xref>&#x000a0;</p>
        <p>In the context of bladder cancer, patients who have supra-vesical diversion usually have a cystectomy.<xref ref-type="bibr" rid="article-140018.r5">[5]</xref>&#x000a0;Indications for supra-vesical diversion without cystectomy are usually for benign disease and include; refractory ureteral obstruction, neurogenic bladder, radiation cystitis, hemorrhagic cystitis, or interstitial cystitis.<xref ref-type="bibr" rid="article-140018.r6">[6]</xref>&#x000a0;Pyocystis can also occur in patients with a physiologically defunctionalized bladder secondary to anuria, such as in patients with end-stage renal failure.<xref ref-type="bibr" rid="article-140018.r7">[7]</xref></p>
        <p>Though mild cases of pyocystis can be managed with conservative treatments of broad-spectrum antibiotics and intermittent bladder irrigation, a cystectomy may be&#x000a0;necessary in cases with resistant infection. There is some debate about whether a cystectomy should be offered at the time of urinary diversion procedures in some cohorts of patients. This is not currently a recommended preventative intervention due to the rarity of pyocystis occurring even in cohorts most at risk relative to the risks of cystectomy.<xref ref-type="bibr" rid="article-140018.r8">[8]</xref></p>
        <p>As pyocytis is a rare condition, there are limited&#x000a0;case reports describing it and low numbers of patients involved&#x000a0;in the published meta-analysis. This may affect the statistical validity of analysis on occurrence and treatment outcomes.</p>
      </sec>
      <sec id="article-140018.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Pyocytis most likely occurs due to the inability of a defunctionalized bladder to expel the epithelial cells and debris that accumulate in the bladder without the flow of urine.<xref ref-type="bibr" rid="article-140018.r9">[9]</xref>&#x000a0;It could also be due to the collection of retrograde prostatic secretions in men and the osmotic transfer of water.<xref ref-type="bibr" rid="article-140018.r10">[10]</xref>&#x000a0;When this collection of debris/secretions becomes infected, pyocystis occurs.</p>
        <p>In a fully functional bladder, the flow of urine prevents the accumulation of debris and subsequent inflammatory and infective processes occurring. Causative organisms are frequently the same as those that most commonly cause lower urinary tract infections, such as E.coli and other gram-negative bacteria. Other common organisms include <italic toggle="yes">P. mirabilis</italic>, <italic toggle="yes">P. aeuginosa</italic>, and <italic toggle="yes">Enterococcus</italic>.<xref ref-type="bibr" rid="article-140018.r11">[11]</xref><xref ref-type="bibr" rid="article-140018.r12">[12]</xref>&#x000a0;Retrograde passage of these organisms along the urethra is the most likely source of infection.<xref ref-type="bibr" rid="article-140018.r6">[6]</xref></p>
        <p>The bladder can become&#x000a0;defunctionalized either iatrogenically or physiologically. Physiological defunctioning occurs because of anuria secondary to end-stage renal failure. Iatrogenic defunctioning results from supravesical urinary diversion. Both result in a lack of urine flushing through the bladder, putting the patient at risk of pyocystis.<xref ref-type="bibr" rid="article-140018.r13">[13]</xref><xref ref-type="bibr" rid="article-140018.r9">[9]</xref></p>
      </sec>
      <sec id="article-140018.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of pyocytis rose following the introduction of supravesical urinary diversion procedures in the 1960s. Reported cases prior to this were rare. The incidence of pyocytis in patients with end-stage&#x000a0;renal disease is unclear in the published literature, but it&#x000a0;is a known complication secondary to anuria in this patient cohort.<xref ref-type="bibr" rid="article-140018.r9">[9]</xref><xref ref-type="bibr" rid="article-140018.r5">[5]</xref></p>
        <p>Pyocystis resulting from iatrogenic bladder defunctioning is more common than from end-stage renal failure.<xref ref-type="bibr" rid="article-140018.r6">[6]</xref>&#x000a0;The reported rate of occurrence of pyocytis varies from 7 to 67% in patients who have had a urinary diversion procedure.<xref ref-type="bibr" rid="article-140018.r11">[11]</xref><xref ref-type="bibr" rid="article-140018.r14">[14]</xref><xref ref-type="bibr" rid="article-140018.r2">[2]</xref><xref ref-type="bibr" rid="article-140018.r15">[15]</xref>&#x000a0;It has also been observed to be more common in female populations.<xref ref-type="bibr" rid="article-140018.r16">[16]</xref>&#x000a0;The reason for this is thought to be the shorter female urethra,&#x000a0;similar to how women are more at risk of urinary tract infections.<xref ref-type="bibr" rid="article-140018.r5">[5]</xref>&#x000a0;</p>
        <p>Culturing of proteus mirabilis in the urine prior to supravesical diversion has been implicated with higher risks of developing pyocystis.<xref ref-type="bibr" rid="article-140018.r17">[17]</xref><xref ref-type="bibr" rid="article-140018.r3">[3]</xref>&#x000a0;Pyocystis develops more often in the first 6&#x000a0;to 12 months following surgery.<xref ref-type="bibr" rid="article-140018.r17">[17]</xref>&#x000a0;Some studies have shown that there is a significantly increased risk of developing pyocystis if the patient has had pelvic irradiation.<xref ref-type="bibr" rid="article-140018.r18">[18]</xref><xref ref-type="bibr" rid="article-140018.r19">[19]</xref></p>
        <p>Pyocystis is also described as empyema cystis and vesical empyema, though these terms are infrequently used and often used in older descriptions of the condition.<xref ref-type="bibr" rid="article-140018.r20">[20]</xref><xref ref-type="bibr" rid="article-140018.r3">[3]</xref>&#x000a0;Because of this, their contribution to epidemiological literature is limited.</p>
      </sec>
      <sec id="article-140018.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The accumulation of cellular debris provides a focus for bacterial infection.<xref ref-type="bibr" rid="article-140018.r1">[1]</xref>&#x000a0; If bacterial infection occurs, pus accumulates due to bacterial cell turnover and the host&#x02019;s inflammatory response. This collection of pus in the bladder is pyocystis. The collection of infected tissue results in the activation of the body&#x02019;s immune response leading to pain, fevers, and systemic inflammatory response syndrome in severe cases.<xref ref-type="bibr" rid="article-140018.r1">[1]</xref>&#x000a0;</p>
        <p>Much like with an abscess or empyema, the body will struggle to get control of the infection due to the difficulty of getting white cells into the purulent fluid. Therefore to manage pyocystis, the purulent tissue must be drained.</p>
      </sec>
      <sec id="article-140018.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Pyocytis will typically present with suprapubic pain, malodorous discharge from the urethra, and fevers for several days prior to admission.<xref ref-type="bibr" rid="article-140018.r12">[12]</xref>&#x000a0;In more severe cases, there may also be other systemic signs of infection, such as loss of appetite, nausea, and vomiting.<xref ref-type="bibr" rid="article-140018.r12">[12]</xref>&#x000a0;</p>
        <p>Patients presenting with signs of systemic infection and accompanying risk factors should be investigated and treated for pyocystis. These risk factors include surgical defunctioning of the bladder or end-stage renal failure. Alternatively, patients with pyocystis may&#x000a0;present with a low-grade fever and some abdominal or pelvic discomfort and may be systemically well. There is a spectrum of presentations for this condition depending on the severity and duration of infection.<xref ref-type="bibr" rid="article-140018.r21">[21]</xref><xref ref-type="bibr" rid="article-140018.r22">[22]</xref></p>
        <p>On examination of the abdomen, there may be a palpable, tender suprapubic mass and inguinal lymphadenopathy.<xref ref-type="bibr" rid="article-140018.r22">[22]</xref>&#x000a0;On inspection of the genitalia, malodorous discharge or frank pus may come from the urethra.<xref ref-type="bibr" rid="article-140018.r17">[17]</xref>&#x000a0;The clinician may find tachycardia, hypotension, and pyrexia when taking basic vital signs.<xref ref-type="bibr" rid="article-140018.r21">[21]</xref></p>
      </sec>
      <sec id="article-140018.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Blood tests often show leukocytosis and a raised C-reactive protein (CRP).<xref ref-type="bibr" rid="article-140018.r13">[13]</xref>&#x000a0;Blood cultures should be taken; however, these often do not isolate an organism.<xref ref-type="bibr" rid="article-140018.r9">[9]</xref><xref ref-type="bibr" rid="article-140018.r21">[21]</xref>&#x000a0;All patients with a differential of pyocytis should be catheterized. This has dual diagnostic and therapeutic benefits. A sample of the bladder contents should be taken for microbiology, cultures, and sensitivities. Most common organisms isolated are <italic toggle="yes">E</italic>.&#x000a0;<italic toggle="yes">coli</italic>,&#x000a0;<italic toggle="yes">Pseudomonas aeruginosa,</italic>&#x000a0;and&#x000a0;<italic toggle="yes">Enterococcus faecalis</italic>.&#x000a0;<italic toggle="yes">Proteus mirabilis and Serratia</italic>&#x000a0;<italic toggle="yes">marcescens</italic>&#x000a0;have also been isolated.<xref ref-type="bibr" rid="article-140018.r12">[12]</xref>&#x000a0;However, in immunocompromised patients, less common pathogens may be isolated.<xref ref-type="bibr" rid="article-140018.r21">[21]</xref></p>
        <p>The diagnosis of pyocytis can be aided by using computed tomography (CT) and ultrasound. The benefit of ultrasound is that it is more easily accessed and can be performed at the bedside. Ultrasound will show a thickened bladder wall and a heterogeneous echogenic collection.<xref ref-type="bibr" rid="article-140018.r13">[13]</xref>&#x000a0;CT scanning may show a thick-walled bladder containing a collection of fluid.<xref ref-type="bibr" rid="article-140018.r22">[22]</xref>&#x000a0;CT scanning with IV contrast is preferred for investigation. However, non-contrast CT will display the same features and is useful in patients with end-stage renal failure.<xref ref-type="bibr" rid="article-140018.r22">[22]</xref><xref ref-type="bibr" rid="article-140018.r2">[2]</xref><xref ref-type="bibr" rid="article-140018.r9">[9]</xref></p>
        <p>Investigation and diagnosis of pyocytis&#x000a0;may also include cystoscopy to aid bladder access, evacuate toxic collections, and biopsy&#x000a0;thick-walled bladder to exclude malignancy.<xref ref-type="bibr" rid="article-140018.r4">[4]</xref><xref ref-type="bibr" rid="article-140018.r2">[2]</xref></p>
      </sec>
      <sec id="article-140018.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>In patients displaying signs of urosepsis, initial treatment should include fluid resuscitation and administration of broad-spectrum IV antibiotics.<xref ref-type="bibr" rid="article-140018.r21">[21]</xref>&#x000a0;High-risk patients should be treated with antibiotics that cover opportunistic infections. High-risk patients include those who are receiving dialysis, chemotherapy, IV antibiotics, or&#x000a0;who have recently been discharged from the hospital.<xref ref-type="bibr" rid="article-140018.r1">[1]</xref>&#x000a0;Some patients may have pre-existing urine cultures; these sensitivities will help guide treatment.</p>
        <p>Immediate catheterization of the patient is important in patients with suspected pyocystis. This has dual therapeutic and diagnostic benefits through drainage of infected tissue and acquiring pus for culture, respectively. Once sensitivities are obtained, the antibiotic choice can be tailored to reflect this.</p>
        <p>Following catheterization, bladder irrigation should be used to prevent the re-accumulation of infected debris and to assist in clearing the initial collection. This can be continuous irrigation using a three-way catheter or can be done using frequent bladder washouts. Irrigation should be continued in the community for up to 3 months, several times a week, to&#x000a0;attempt to eradicate any infection.<xref ref-type="bibr" rid="article-140018.r12">[12]</xref>&#x000a0;Intra-vesical antibiotics have been used to treat pyocytis, typically gentamycin or neomycin. Normal saline is also an option.<xref ref-type="bibr" rid="article-140018.r23">[23]</xref><xref ref-type="bibr" rid="article-140018.r17">[17]</xref><xref ref-type="bibr" rid="article-140018.r24">[24]</xref></p>
        <p>The previous positive urine culture of&#x000a0;<italic toggle="yes">Proteus mirabilis</italic>&#x000a0;is a significant risk factor for the development of pyocystis following urinary diversion procedures.<xref ref-type="bibr" rid="article-140018.r25">[25]</xref>&#x000a0;Some have argued that patients with positive pre-operative urine culture for&#x000a0;<italic toggle="yes">Proteus mirabilis</italic>&#x000a0;should be considered for a cystectomy.<xref ref-type="bibr" rid="article-140018.r5">[5]</xref>&#x000a0;Alternatively, in sexually inactive females, the Spence-Allen procedure can be considered to prevent the development of pyocytis.<xref ref-type="bibr" rid="article-140018.r3">[3]</xref><xref ref-type="bibr" rid="article-140018.r17">[17]</xref>&#x000a0;This involves the creation of a vesicovaginal&#x000a0;fistula to allow continuous drainage of bladder contents through the vagina.<xref ref-type="bibr" rid="article-140018.r26">[26]</xref>&#x000a0;</p>
        <p>Cystectomy may be&#x000a0;necessary for patients not responding to IV antibiotics and irrigation. The need for cystectomy in patients with pyocytis is reportedly up to 25%.<xref ref-type="bibr" rid="article-140018.r4">[4]</xref><xref ref-type="bibr" rid="article-140018.r15">[15]</xref></p>
      </sec>
      <sec id="article-140018.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>In females with pyocytis urethral discharge can be accidentally misidentified as vaginal discharge,&#x000a0;leading to misdiagnosis.<xref ref-type="bibr" rid="article-140018.r27">[27]</xref></p>
      </sec>
      <sec id="article-140018.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis&#x000a0;of pyocystis depends on the severity of the infection and systemic involvement. Milder cases&#x000a0;may be managed in the community with antibiotics and intermittent bladder irrigation. Severe non-resolving infections require surgical management with either the Spence-Allen procedure or total cystectomy.</p>
        <p>The need for a cystectomy in patients diagnosed with pyocytis is reported to be between 18.7% and 25%, however, due to the relative rarity of the condition, the number of cases in the studies was low, and a meta-analysis of a larger patient cohort is required to establish more accurate figures.<xref ref-type="bibr" rid="article-140018.r4">[4]</xref><xref ref-type="bibr" rid="article-140018.r15">[15]</xref></p>
      </sec>
      <sec id="article-140018.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of pyocytis include the need for surgical management, including the need for a total cystectomy. Sepsis and the corresponding complication can also occur in patients with pyocystis and can result in death.<xref ref-type="bibr" rid="article-140018.r12">[12]</xref></p>
      </sec>
      <sec id="article-140018.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Pyocystis is a severe condition that can result in prolonged hospital stays, significant additional surgery, and death. Patients at risk of it should be informed of this and the common symptoms. These symptoms include suprapubic pain, malodorous discharge, and fevers. Patients at risk of pyocystis include those who have had surgical defunctioning of the bladder or have anuria because of renal failure.</p>
        <p>High-risk patients of these groups include those who are also on dialysis, immunosuppressed, or have a previous culture for proteus mirabilis. Management of other medical conditions and lifestyle factors such as smoking and diabetes may also be of benefit.<xref ref-type="bibr" rid="article-140018.r13">[13]</xref><xref ref-type="bibr" rid="article-140018.r7">[7]</xref>&#x000a0;</p>
        <p>Rapid identification and treatment of pyocystis are crucial to the successful medical management of pyocystis. Delayed intervention may result in the need for surgical intervention and a poorer prognosis.<xref ref-type="bibr" rid="article-140018.r12">[12]</xref></p>
      </sec>
      <sec id="article-140018.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Many of these patients have a complex urological history with multiple, complex procedures throughout childhood into adult life. The patient may not be aware or able to communicate their anatomical bladder remains in situ hence why it can be ignored as a source during septic episodes. Always consider pyocystis in atypical or recurrent infections in patients with prior urinary diversion.</p>
      </sec>
      <sec id="article-140018.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>All members of the interprofessional health care team involved in the care of the above patient cohorts who are susceptible to developing pyocytis must be aware of it as a complication. They should also be aware of what puts those patients at higher risk of developing it. The team can be comprised of clinicians (MDs, DOs, NPs, and PAs), specialists (infectious disease, urology), nursing staff, and pharmacists, which may include an infectious disease specialty pharmacist. All team members must engage in open communication and meticulous record keeping of each patient encounter and report to other team members if there are any patient status changes or concerns. This interprofessional paradigm will help optimize patient outcomes. [Level 5]</p>
        <p>The importance of identification of urethral discharge as opposed to vaginal discharge is an important differentiator for pyocystis to allow correct management to occur. Rapid identification in the community of the condition as a differential is essential for timely investigation, diagnosis, and intervention. Education about this rare condition is crucial to avoid&#x000a0;potential complications in this patient cohort.</p>
      </sec>
      <sec id="article-140018.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140018&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140018">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/kidney-health/pyocystis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140018">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140018/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140018">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-140018.s16">
        <title>References</title>
        <ref id="article-140018.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamel</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tourchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tart</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Raheem</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Houston</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bissada</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pyocystis: a systematic review.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>917</fpage>
            <page-range>917-926</page-range>
            <pub-id pub-id-type="pmid">28265966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Min</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>A forgotten complication of a defunctionalized urinary bladder: pyocystis.</article-title>
            <source>Intern Emerg Med</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>691</fpage>
            <page-range>691-2</page-range>
            <pub-id pub-id-type="pmid">24554081</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dretler</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>The occurrence of empyema cystis: management of the bladder to be defunctionalized.</article-title>
            <source>J Urol</source>
            <year>1972</year>
            <month>Jul</month>
            <volume>108</volume>
            <issue>1</issue>
            <fpage>82</fpage>
            <page-range>82-4</page-range>
            <pub-id pub-id-type="pmid">5034022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fazili</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bhat</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Masood</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Palmer</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Mufti</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Fate of the leftover bladder after supravesical urinary diversion for benign disease.</article-title>
            <source>J Urol</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>176</volume>
            <issue>2</issue>
            <fpage>620</fpage>
            <page-range>620-1</page-range>
            <pub-id pub-id-type="pmid">16813905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morey</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Re: Pyocystis after urinary diversion for incontinence-is a concomitant cystectomy necessary?</article-title>
            <source>J Urol</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>192</volume>
            <issue>2</issue>
            <fpage>449</fpage>
            <pub-id pub-id-type="pmid">25035008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Falagas</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Vergidis</surname>
                <given-names>PI</given-names>
              </name>
            </person-group>
            <article-title>Irrigation with antibiotic-containing solutions for the prevention and treatment of infections.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>11</issue>
            <fpage>862</fpage>
            <page-range>862-7</page-range>
            <pub-id pub-id-type="pmid">16216099</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ito</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Pyocystis in an anuric patient undergoing chronic haemodialysis.</article-title>
            <source>Nephrology (Carlton)</source>
            <year>2017</year>
            <month>May</month>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>420</fpage>
            <pub-id pub-id-type="pmid">28378536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lawrence</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Stone</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pyocystis after urinary diversion for incontinence--is a concomitant cystectomy necessary?</article-title>
            <source>Urology</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>82</volume>
            <issue>5</issue>
            <fpage>1161</fpage>
            <page-range>1161-5</page-range>
            <pub-id pub-id-type="pmid">23978370</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bibb</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Servilla</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Gibel</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Kinne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Hartshsorne</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Tzamaloukas</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Pyocystis in patients on chronic dialysis. A potentially misdiagnosed syndrome.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2002</year>
            <volume>34</volume>
            <issue>3</issue>
            <fpage>415</fpage>
            <page-range>415-8</page-range>
            <pub-id pub-id-type="pmid">12899239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ray</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taguchi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>MacKinnon</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>The pyocystis syndrome.</article-title>
            <source>Br J Urol</source>
            <year>1971</year>
            <month>Oct</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>583</fpage>
            <page-range>583-5</page-range>
            <pub-id pub-id-type="pmid">5118137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adeyoju</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Thornhill</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The defunctionalized bladder.</article-title>
            <source>Int Urogynecol J Pelvic Floor Dysfunct</source>
            <year>1998</year>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-51</page-range>
            <pub-id pub-id-type="pmid">9657178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Remer</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Peacock WFIV</surname>
              </name>
            </person-group>
            <article-title>Pyocystis: two case reports of patients in renal failure.</article-title>
            <source>J Emerg Med</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-3</page-range>
            <pub-id pub-id-type="pmid">10903459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sanda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kashiwagi</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Pyocystis.</article-title>
            <source>Am J Med</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>135</volume>
            <issue>2</issue>
            <fpage>e49</fpage>
            <page-range>e49-e50</page-range>
            <pub-id pub-id-type="pmid">34560037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stewart</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Cass</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ireland</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Experience with pyocystis following intestinal conduit urinary diversion.</article-title>
            <source>J Urol</source>
            <year>1973</year>
            <month>Mar</month>
            <volume>109</volume>
            <issue>3</issue>
            <fpage>375</fpage>
            <page-range>375-6</page-range>
            <pub-id pub-id-type="pmid">4692368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guerrier</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Persky</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Experiences with pyocystis.</article-title>
            <source>Arch Surg</source>
            <year>1971</year>
            <month>Jul</month>
            <volume>103</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-5</page-range>
            <pub-id pub-id-type="pmid">5088432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinberg</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Pyocystis.</article-title>
            <source>J Urol</source>
            <year>1977</year>
            <month>Jun</month>
            <volume>117</volume>
            <issue>6</issue>
            <fpage>798</fpage>
            <page-range>798-9</page-range>
            <pub-id pub-id-type="pmid">875164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Granados</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Salvador</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vicente</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Villavicencio</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Follow-up of the remaining bladder after supravesical urinary diversion.</article-title>
            <source>Eur Urol</source>
            <year>1996</year>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>308</fpage>
            <page-range>308-11</page-range>
            <pub-id pub-id-type="pmid">8740037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adeyoju</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Thornhill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Grainger</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>McDermott</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>The fate of the defunctioned bladder following supravesical urinary diversion.</article-title>
            <source>Br J Urol</source>
            <year>1996</year>
            <month>Jul</month>
            <volume>78</volume>
            <issue>1</issue>
            <fpage>80</fpage>
            <page-range>80-3</page-range>
            <pub-id pub-id-type="pmid">8795405</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eigner</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Freiha</surname>
                <given-names>FS</given-names>
              </name>
            </person-group>
            <article-title>The fate of the remaining bladder following supravesical diversion.</article-title>
            <source>J Urol</source>
            <year>1990</year>
            <month>Jul</month>
            <volume>144</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-3</page-range>
            <pub-id pub-id-type="pmid">2359176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herwig</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Empyema cystis treated by intermittent self-catherterization.</article-title>
            <source>J Urol</source>
            <year>1975</year>
            <month>May</month>
            <volume>113</volume>
            <issue>5</issue>
            <fpage>719</fpage>
            <pub-id pub-id-type="pmid">1168734</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elsayed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Finn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dapaah-Afriyie</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Unusual organism causing pyocystis in an immunosuppressed haemodialysis patient.</article-title>
            <source>BMJ Case Rep</source>
            <year>2016</year>
            <month>Mar</month>
            <day>30</day>
            <volume>2016</volume>
            <pub-id pub-id-type="pmid">27030457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stafford</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Prybys</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Pyocystis and prostate abscess in a hemodialysis patient in the emergency department.</article-title>
            <source>West J Emerg Med</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>655</fpage>
            <page-range>655-8</page-range>
            <pub-id pub-id-type="pmid">25247036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waites</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Canupp</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Roper</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Camp</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2006</year>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-26</page-range>
            <pub-id pub-id-type="pmid">16859225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hosaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kobayashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Igawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nishizawa</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Fate of tetraplegic patients managed by ileal conduit for urinary control: long-term follow-up.</article-title>
            <source>Int J Urol</source>
            <year>2002</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>253</fpage>
            <page-range>253-6</page-range>
            <pub-id pub-id-type="pmid">12060437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherwin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>King</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hasen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>May</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Single-dose intravesical amikacin instillation for pyocystis in a patient with autonomic dysreflexia: A case report.</article-title>
            <source>J Spinal Cord Med</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>965</fpage>
            <page-range>965-968</page-range>
            <pub-id pub-id-type="pmid">33983103</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spence</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>Vaginal vesicostomy for empyema of the defunctionalized bladder.</article-title>
            <source>J Urol</source>
            <year>1971</year>
            <month>Dec</month>
            <volume>106</volume>
            <issue>6</issue>
            <fpage>862</fpage>
            <page-range>862-4</page-range>
            <pub-id pub-id-type="pmid">5116304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140018.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wilkinson</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>DG</given-names>
              </name>
            </person-group>
            <article-title>Supravesical diversion for incontinence: a long-term follow-up.</article-title>
            <source>Br J Urol</source>
            <year>1997</year>
            <month>Mar</month>
            <volume>79</volume>
            <issue>3</issue>
            <fpage>348</fpage>
            <page-range>348-53</page-range>
            <pub-id pub-id-type="pmid">9117212</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
